Skip to content

Drug interactions

Lomitapide + Sitagliptin

Severity: Minor

Lomitapide and Sitagliptin: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lomitapide inhibits P-glycoprotein and may increase sitagliptin concentrations. Because sitagliptin has a wide safety margin, the clinical effect is expected to be small.

What this interaction means in plain words

Lomitapide and Sitagliptin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Lomitapide belongs to Cardiovascular; Sitagliptin belongs to Endocrine.

Evidence level: Low

Why it happens

Inhibition of P-glycoprotein efflux by lomitapide may increase sitagliptin exposure.

What to do

No routine dose adjustment is needed. Monitor glucose and sitagliptin tolerability when the combination is started.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lomitapide and Sitagliptin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Lomitapide with Sitagliptin?

MediHelp rates the interaction as minor. Lomitapide and Sitagliptin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Lomitapide inhibits P-glycoprotein and may increase sitagliptin concentrations. Because sitagliptin has a wide safety margin, the clinical effect is expected to be small.

How serious is the interaction between Lomitapide and Sitagliptin?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine dose adjustment is needed. Monitor glucose and sitagliptin tolerability when the combination is started.

What other medicines interact with Sitagliptin?

MediHelp also lists interactions of Sitagliptin with, for example, Albiglutide, Amlodipine-benazepril, Aripiprazole. The full list is on the Sitagliptin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in